Join us for a virtual KOL event with Pulmatrix, featuring Stewart J. Tepper, MD (Geisel School of Medicine at Dartmouth College) who will discuss the current treatment landscape for migraine patients, along with the mechanism of action and clinical profile of inhaled dihydroergotamine (DHE) treatments.

The event will highlight and explore PUR3100, an orally inhaled DHE delivered using Pulmatrix’s iSPERSE™ technology, that recently completed a Phase 1 study for the treatment of acute migraine. Pulmatrix leadership will provide insight into the Phase 1 study data, along with future clinical plans.

A live question and answer session will follow the formal presentations.

Speaker Biography

Stewart J. Tepper, MD is a Professor of Neurology at the Geisel School of Medicine at Dartmouth College in Hanover, New Hampshire. He is Director of the Dartmouth Headache Center in the Department of Neurology of Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire. Dr Tepper received his undergraduate degree cum laude in the study of the nervous system/psychobiology from Yale College, New Haven, Connecticut, and attended Cornell University Medical College in New York City. He completed his Neurology residency at the Longwood Area Harvard program, Boston, Massachusetts, and has been board certified in Headache Medicine since 2006.

Dr Tepper was Director of the Scottsdale Headache Symposium CME course of the American Headache Society from 2008 to 2020. He was Editor-in-Chief of the journal Headache Currents and Associate Editor for the journal Headache from 2012-2020. He has published more than 470 peer-reviewed manuscripts, editorials, and books on Headache Medicine.  Dr. Tepper serves on the Executive Board of Directors and is the Corporate Liaison for the American Headache Society. He serves on the AHS Education, Exhibits, and Finance Committees. He also serves on the Governance Committee and Board of Directors of the American Migraine Foundation.